Scott E. Hensley
Impact in
- Infectious Diseases top 0.2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Epidemiology top 0.5%
- Influenza Virus Research Studies
Papers in
- Epidemiology 77
- Influenza Virus Research Studies 73
-
- SARS-CoV-2 and COVID-19 Research 30
- COVID-19 Clinical Research Studies 8
- Co-authors
- Sarah E. Cobey (11 shared papers)Kaela Parkhouse (14 shared papers)Jonathan Wilson Yewdell (11 shared papers)Seth J. Zost (9 shared papers)Jack R. Bennink (8 shared papers)Hildegund C.J. Ertl (10 shared papers)Heather D. Hickman (4 shared papers)Sigrid Gouma (13 shared papers)
- Journals
- Journal of Virology (15 papers)Cell Reports (6 papers)Proceedings of the National Academy of Sciences (6 papers)Science Immunology (6 papers)PLoS Pathogens (5 papers)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Scott E. Hensley
137 papers receiving 13.3k citations
Scott E. Hensley's Hit Papers
Peers
Comparison fields: 5 of 129
- Infectious Diseases 5.5k
- Epidemiology 3.6k
- Immunology 1.9k
- Virology 283
- Obstetrics and Gynecology 242
Countries citing papers authored by Scott E. Hensley
This map shows the geographic impact of Scott E. Hensley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott E. Hensley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott E. Hensley more than expected).
Fields of papers citing papers by Scott E. Hensley
This network shows the impact of papers produced by Scott E. Hensley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott E. Hensley. The network helps show where Scott E. Hensley may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott E. Hensley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 144 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications Hit paper breakdown → | 2020 | 1226 |
| 2 | Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination Hit paper breakdown → | 2017 | 744 |
| 3 | mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern Hit paper breakdown → | 2021 | 682 |
| 4 | 2020 | 594 | |
| 5 | Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination Hit paper breakdown → | 2021 | 514 |
| 6 | Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains Hit paper breakdown → | 2017 | 461 |
| 7 | 2018 | 434 | |
| 8 | Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy Hit paper breakdown → | 2021 | 422 |
| 9 | CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer Hit paper breakdown → | 2021 | 412 |
| 10 | 2009 | 400 | |
| 11 | Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination Hit paper breakdown → | 2021 | 392 |
| 12 | Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection Hit paper breakdown → | 2021 | 319 |
| 13 | A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes Hit paper breakdown → | 2022 | 277 |
| 14 | 2018 | 240 | |
| 15 | 2008 | 221 | |
| 16 | 2016 | 208 | |
| 17 | 2021 | 205 | |
| 18 | 2007 | 193 | |
| 19 | 2017 | 191 | |
| 20 | 2017 | 187 |
About Scott E. Hensley
Scott E. Hensley is a scholar working on Epidemiology, Infectious Diseases, Immunology, Obstetrics and Gynecology and Genetics, having authored 144 papers that have together received 13.5k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (73 papers), SARS-CoV-2 and COVID-19 Research (30 papers), Immunotherapy and Immune Responses (10 papers), COVID-19 Clinical Research Studies (8 papers), T-cell and B-cell Immunology (7 papers), Virus-based gene therapy research (7 papers), Health Services Management and Policy (4 papers) and COVID-19 Impact on Reproduction (4 papers). The work is most often cited by research in Infectious Diseases (5.5k citations), Epidemiology (3.6k citations), Immunology (1.9k citations), Virology (283 citations) and Obstetrics and Gynecology (242 citations). Scott E. Hensley has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Sarah E. Cobey, Kaela Parkhouse, Jonathan Wilson Yewdell, Seth J. Zost, Jack R. Bennink, Hildegund C.J. Ertl, Heather D. Hickman, Sigrid Gouma, Benjamin S. Chambers and Patrick C. Wilson. Their work appears in journals such as Journal of Virology, Cell Reports, Proceedings of the National Academy of Sciences, Science Immunology and PLoS Pathogens.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.